|
 |
|
‘Software-Guided Insulin Dosing Decreases
Glycemic Variability in Critically Ill Patients’
Poster Presentation from the 2011 International
Hospital Diabetes Meeting, Barcelona, Spain
Click here |
|
|
|
|
|
|
If you’re still using paper protocols to
manage your critical care inpatients needing IV insulin... |
|
|
|
...we’d like to share some numbers regarding the
use of GlucoStabilizer
insulin dosing software
for improving glycemic management: |
|
|
|
|
|
# of ICU patient BG levels
controlled |
70,193* |
|
# of IV insulin doses
administered |
2,398,665* |
|
% of blood glucoses <70mg/dL |
1.80%* |
|
% of blood glucoses <40mg/dL |
0.06%* |
|
|
|
|
|
|
See for yourself how
GlucoStabilizer is helping inpatient diabetes
care teams
improve critical outcomes and reduce length of
stay by
contacting us today.
|
|
|
GlucoStabilizer Selected to Support $25
Million NIH Grant
August 17, 2011 - Charlottesville, VA -
The University of Virginia has received a $25
million grant that could lead to breakthroughs
for diabetic stroke patients. The grant, from
the National Institutes of Health, provides
money for UVa to lead a 56-center nationwide
clinical trial of a new treatment for acute
stroke victims with hyperglycemia, or high blood
sugar.
The new treatment involves giving patients an
insulin IV starting within 12 hours of a stroke
for up to three days. The amount of insulin will
be determined using MAS Informatics
GlucoStabilizer insulin dosing software, which
calculates the IV dose based on the patient’s
current glucose reading and instructs the
caregiver to adjust the IV drip accordingly.
more > |
|
|
